TY - JOUR
T1 - Altered distribution of juxtaparanodal K v1.2 subunits mediates peripheral nerve hyperexcitability in type 2 diabetes mellitus
AU - Zenker, Jennifer
AU - Poirot, Olivier
AU - Charles, Anne Sophie de Preux
AU - Arnaud, Estelle
AU - Médard, Jean Jacques
AU - Lacroix, Catherine
AU - Kuntzer, Thierry
AU - Chrast, Roman
PY - 2012/5/30
Y1 - 2012/5/30
N2 - Peripheral nerve hyperexcitability (PNH) is one of the distal peripheral neuropathy phenotypes often present in patients affected by type 2 diabetes mellitus (T2DM). Through in vivo and ex vivo electrophysiological recordings in db/db mice, a model of T2DM, we observed that, in addition to reduced nerve conduction velocity, db/db mice also develop PNH. By using pharmacological inhibitors, we demonstrated that the PNH is mediated by the decreased activity of K v1-channels. In agreement with these data, we observed that the diabetic condition led to a reduced presence of the K v1.2-subunits in juxtaparanodal regions of peripheral nerves in db/db mice and in nerve biopsies fromT2DMpatients. Together, these observations indicate that theT2DMcondition leads to potassium channel-mediated PNH, thus identifying them as a potential drug target to treat some of the DPN related symptoms.
AB - Peripheral nerve hyperexcitability (PNH) is one of the distal peripheral neuropathy phenotypes often present in patients affected by type 2 diabetes mellitus (T2DM). Through in vivo and ex vivo electrophysiological recordings in db/db mice, a model of T2DM, we observed that, in addition to reduced nerve conduction velocity, db/db mice also develop PNH. By using pharmacological inhibitors, we demonstrated that the PNH is mediated by the decreased activity of K v1-channels. In agreement with these data, we observed that the diabetic condition led to a reduced presence of the K v1.2-subunits in juxtaparanodal regions of peripheral nerves in db/db mice and in nerve biopsies fromT2DMpatients. Together, these observations indicate that theT2DMcondition leads to potassium channel-mediated PNH, thus identifying them as a potential drug target to treat some of the DPN related symptoms.
UR - http://www.scopus.com/inward/record.url?scp=84861589173&partnerID=8YFLogxK
U2 - 10.1523/JNEUROSCI.0719-12.2012
DO - 10.1523/JNEUROSCI.0719-12.2012
M3 - Article
C2 - 22649228
AN - SCOPUS:84861589173
SN - 0270-6474
VL - 32
SP - 7493
EP - 7498
JO - The Journal of Neuroscience
JF - The Journal of Neuroscience
IS - 22
M1 - 22649228
ER -